SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (22052)6/10/1998 12:43:00 PM
From: Hippieslayer  Read Replies (1) | Respond to of 32384
 
Want to start making bets on how long that 13 base will last?
It was touched upon that this company doesn't give a rats ass about it's investors. Based on the last two years, I'd say that is correct. Yet very few people want to write about this subject here. It doesn't surprise me. The last brick to fall is the earnings brick. If lgnd stock price doesn't respond to finally making it into the black (that is if they get approval and doctors use their drugs)then I think it's safe to say that lgnd was and is a poor investment. Lesson learned, you win some and you lose some.



To: tonyt who wrote (22052)6/10/1998 8:46:00 PM
From: Proton  Respond to of 32384
 
Re: Reading is Fundamental

Looks like LGND is now forming a base at $13 (so much for that $14 base)

Try reading Bob's message again. He said, "something more than your continuous stream of one-liners," not "some more of your continuous stream on one-liners."

Pý

p.s. to B.Z.: Thanks for response and favor. Will reply later... :-)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News